Literature DB >> 14330058

FIBRINOLYTIC EFFECT OF METFORMIN IN CORONARY-ARTERY DISEASE.

R CHAKRABARTI, E D HOCKING, G R FEARNLEY.   

Abstract

Entities:  

Keywords:  BLOOD CHOLESTEROL; BLOOD COAGULATION TESTS; CLINICAL RESEARCH; CORONARY DISEASE; FIBRINOGEN; FIBRINOLYSIS; INTERMITTENT CLAUDICATION; METFORMIN; MIDDLE AGE; PLACEBOS

Mesh：

Substances：

Year:  1965        PMID： 14330058     DOI： 10.1016/s0140-6736(65)92383-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Phenoformin as a fibrinolytic drug.

Authors:  G R Fearnley
Journal:  Postgrad Med J       Date:  1968-06       Impact factor: 2.401

2.  Oral fibrinolytic agents.

Authors:  G R Fearnley; R Chakrabarti
Journal:  Br Med J       Date:  1968-08-24

Review 3.  Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

Authors:  Shelley R Salpeter; Elizabeth Greyber; Gary A Pasternak; Edwin E Salpeter
Journal:  Cochrane Database Syst Rev       Date:  2010-04-14

Review 4.  Metformin--mode of action and clinical implications for diabetes and cancer.

Authors:  Ida Pernicova; Márta Korbonits
Journal:  Nat Rev Endocrinol       Date:  2014-01-07       Impact factor: 43.330

5.  Metformin treatment in NIDDM patients with mild renal impairment.

Authors:  V Connolly; C M Kesson
Journal:  Postgrad Med J       Date:  1996-06       Impact factor: 2.401

6.  Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line Hep G2. Metformin inhibits the stimulating effect of insulin.

Authors:  F Anfosso; N Chomiki; M C Alessi; P Vague; I Juhan-Vague
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

Review 7.  Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis.

Authors:  I Juhan-Vague; M C Alessi; P Vague
Journal:  Diabetologia       Date:  1991-07       Impact factor: 10.122

Review 8.  Treatment of non-insulin-dependent diabetes mellitus and its complications. A state of the art review.

Authors:  A Ilarde; M Tuck
Journal:  Drugs Aging       Date:  1994-06       Impact factor: 3.923

Review 9.  A marriage of two "Methusalem" drugs for the treatment of psoriasis?: Arguments for a pilot trial with metformin as add-on for methotrexate.

Authors:  Hartmut Glossmann; Norbert Reider
Journal:  Dermatoendocrinol       Date:  2013-04-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.